Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Heavy targeted modification method for herpes simplex viruses and application thereof

A herpes simplex virus, targeted modification technology, applied in the field of medicine and biology, can solve the problems of unusable tumor patients and large clinical limitations, and achieve the effects of improving safety, avoiding immune response, and reducing toxic and side effects

Inactive Publication Date: 2011-09-21
FUDAN UNIV
View PDF4 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The current solution mainly relies on intratumoral injection, but this method has relatively large clinical limitations, especially for patients whose tumors have spread
Furthermore, oncolytic HSV also has strong immunogenicity, which is also a serious challenge for repeated administration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Heavy targeted modification method for herpes simplex viruses and application thereof
  • Heavy targeted modification method for herpes simplex viruses and application thereof
  • Heavy targeted modification method for herpes simplex viruses and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Cultivation and purification of HSV-1

[0043] Vero cells were inoculated in a cell culture dish with a diameter of 12.5 cm. When the cells grew to 80% full, the cell culture medium was replaced with DMEM medium containing 5% newborn calf serum, and the virus HSV was inoculated with MOI=0.05. at 37°C with 5% CO 2 Continue culturing for 72 hours in the incubator. The cell culture supernatant and cell debris were collected into sterile cryopreservation tubes and stored at -80°C.

[0044] The virus supernatant and cells collected above were repeatedly frozen and thawed three times, so as to fully lyse the cells and release the HSV virus particles in the cells. Put the virus liquid that had been frozen and thawed three times into a centrifuge tube, centrifuge at 5000 rpm at 4°C for 10 minutes, and collect the virus supernatant. Centrifuge at 12000 rpm at 4°C for 30 minutes to further remove cell debris in the virus supernatant. Add 25 ml of the preliminarily purified vi...

Embodiment 2

[0046] Synthesis and Characterization of FA-PEG

[0047] Folic acid and NHS form activated ester, that is, folic acid is dissolved in dimethyl sulfoxide (DMSO), reacted with dicyclohexylcarbodiimide (DCC), n-hydroxysuccinamide at a molar ratio of 1:2:2 , stirred for 18 hours, and the whole reaction was carried out under nitrogen protection. The resulting suspension was centrifuged at 15,000 rpm for 30 minutes to remove white insoluble matter and obtain a yellow supernatant.

[0048] NH with a molar ratio of 1:8 to the folic acid activator 2 -PEG-COOH was dissolved in DMSO, reacted with folic acid activator under the condition of nitrogen protection for 4 hours, dialyzed the obtained substance in DMSO and ultrapure water at 4°C for 3 days and 2 days respectively, and the final product was in Freeze-dry at -20°C.

[0049] Take a part of the FA-PEG freeze-dried product (about 5 mg) and dissolve it in deuterated DMSO, and detect it by nuclear magnetic resonance to confirm the r...

Embodiment 3

[0051] FA-PEGylation of herpes simplex virus

[0052] Dissolve methoxy-PEG-NHS (mPEG) in 2ml HBSS, add HSV (the ratio of mPEG to HSV is 1PFU, add 1×10 7 mPEG molecules), reacted in ice bath for 4 hours. The PEG-FA obtained after the reaction was dialyzed in ultrapure water at 4°C for 2 days, and the final product was stored at -80°C.

[0053] Dissolve FA-PEG-COOH in 2ml HBSS, add EDC and NHS for activation, the molar ratio is 1:10:10, react at room temperature for 1 hour, take the activated FA-PEG-COOH and dissolve it in 2ml HBSS, add HSV (The ratio of HSV to FA-PEG-COOH is 1PFU of HSV adding 1×10 7 FA-PEG-COOH molecules), reacted in ice bath for 4 hours. The PEG-FA obtained after the reaction was dialyzed in ultrapure water at 4°C for 2 days, and the final product FA-PEG-HSV was stored at -80°C.

[0054] The purity of FA-PEG-HSV was further detected, specifically: the fluorescein ammonia dye was dissolved in acetone to prepare a 7 mg / mL fluoresceinamide solution. Add 900...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Luminous wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of medicinal biotechnology and in particular relates to a heavy targeted modification method for herpes simplex viruses (HSV) and application thereof. In the method, surface glycoprotein of the HSV is chemically modified by using an allogenic targeted substance, particularly pegylation folic acid, so that the natural cell tropism is deprived and specifically transduced into tumor cells or tissues and does not infect other normal cells or tissues. By the method, the capacity of the HSV of specifically infecting the tumor cells can be effectively improved; immunoreaction and in vivo neutralization of antibodies are avoided; toxic or side effect is reduced; and safety is improved.

Description

technical field [0001] The invention belongs to the technical field of medicine and biology, and in particular relates to a retargeting modification method of herpes simplex virus, which can effectively improve the ability of herpes simplex virus to specifically infect tumor cells, avoid immune reactions and neutralizing antibodies in vivo, and reduce Toxic and side effects, improve safety. Background technique [0002] Herpes simplex virus (HSV) is an enveloped double-stranded DNA virus, usually divided into type I (HSV-1) and type II (HSV-2) according to the difference in antigenicity. Type I herpes disease is mainly transmitted through close contact with the respiratory tract, skin and mucous membranes, and infects the skin mucous membranes and organs above the waist. Type II herpes virus mainly exists in women's cervix, vagina, vulva skin and men's penis, urethra, etc. It is the chief culprit that causes genital inflammation and herpes. Type I mainly causes infections ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N7/00A61K47/48A61K48/00A61P35/00
Inventor 田聆郭圣荣薛京伦
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com